End-of-day quote
Shanghai S.E.
23:00:00 21/05/2024 BST
|
5-day change
|
1st Jan Change
|
23.72
CNY
|
-2.83%
|
|
-4.55%
|
+17.54%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,423
|
14,154
|
9,280
|
8,074
|
9,490
|
-
|
-
|
Enterprise Value (EV)
1 |
12,423
|
14,154
|
9,280
|
8,074
|
9,490
|
9,490
|
9,490
|
P/E ratio
|
28
x
|
37.2
x
|
20.7
x
|
18.7
x
|
18
x
|
15.2
x
|
13.1
x
|
Yield
|
-
|
-
|
2.41%
|
2.68%
|
2.8%
|
3.35%
|
3.46%
|
Capitalization / Revenue
|
6.71
x
|
6.15
x
|
3.76
x
|
3.28
x
|
3.14
x
|
2.71
x
|
2.37
x
|
EV / Revenue
|
6.71
x
|
6.15
x
|
3.76
x
|
3.28
x
|
3.14
x
|
2.71
x
|
2.37
x
|
EV / EBITDA
|
23.9
x
|
29.1
x
|
15.8
x
|
13.9
x
|
14
x
|
12.1
x
|
10.5
x
|
EV / FCF
|
-
|
635,018,696
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
6.83
x
|
7.12
x
|
4.07
x
|
3.24
x
|
3.4
x
|
3.02
x
|
2.68
x
|
Nbr of stocks (in thousands)
|
400,090
|
400,388
|
400,021
|
400,090
|
400,090
|
-
|
-
|
Reference price
2 |
31.05
|
35.35
|
23.20
|
20.18
|
23.72
|
23.72
|
23.72
|
Announcement Date
|
07/04/21
|
27/04/22
|
27/03/23
|
28/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,850
|
2,302
|
2,471
|
2,461
|
3,025
|
3,508
|
4,010
|
EBITDA
1 |
518.8
|
486.8
|
586.8
|
579
|
677
|
786.6
|
903.6
|
EBIT
1 |
445.3
|
392.9
|
481.1
|
474.6
|
574.8
|
682.5
|
794.2
|
Operating Margin
|
24.07%
|
17.07%
|
19.47%
|
19.28%
|
19%
|
19.45%
|
19.81%
|
Earnings before Tax (EBT)
1 |
443.4
|
391.4
|
482.8
|
474.8
|
574.6
|
682.3
|
794.1
|
Net income
1 |
410.9
|
380.3
|
447
|
431.2
|
527
|
625.8
|
726.7
|
Net margin
|
22.21%
|
16.52%
|
18.09%
|
17.52%
|
17.42%
|
17.84%
|
18.12%
|
EPS
2 |
1.110
|
0.9500
|
1.120
|
1.080
|
1.315
|
1.564
|
1.818
|
Free Cash Flow
|
-
|
22.29
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
0.97%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
4.58%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
5.86%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.5600
|
0.5400
|
0.6650
|
0.7950
|
0.8200
|
Announcement Date
|
07/04/21
|
27/04/22
|
27/03/23
|
28/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 S1
|
2022 Q3
|
---|
Net sales
1 |
552.8
|
-
|
636.9
|
EBITDA
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
|
59.85
|
208.7
|
-
|
Net margin
|
10.83%
|
-
|
-
|
EPS
|
-
|
0.5200
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
27/04/22
|
17/08/22
|
30/10/22
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
22.3
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
33.8%
|
20.3%
|
21%
|
18.3%
|
19.2%
|
20.2%
|
20.5%
|
ROA (Net income/ Total Assets)
|
24.4%
|
17%
|
17.1%
|
-
|
16.1%
|
17.3%
|
18.1%
|
Assets
1 |
1,681
|
2,235
|
2,615
|
-
|
3,268
|
3,607
|
4,016
|
Book Value Per Share
2 |
4.540
|
4.970
|
5.700
|
6.230
|
6.980
|
7.850
|
8.840
|
Cash Flow per Share
2 |
1.010
|
0.6400
|
1.260
|
1.020
|
1.400
|
1.190
|
1.770
|
Capex
1 |
97.3
|
233
|
133
|
88.1
|
132
|
155
|
128
|
Capex / Sales
|
5.26%
|
10.14%
|
5.38%
|
3.58%
|
4.35%
|
4.41%
|
3.19%
|
Announcement Date
|
07/04/21
|
27/04/22
|
27/03/23
|
28/04/24
|
-
|
-
|
-
|
Last Close Price
23.72
CNY Average target price
27.16
CNY Spread / Average Target +14.49% Consensus |
1st Jan change
|
Capi.
|
---|
| +17.54% | 1.35B | | +3.79% | 105B | | -6.59% | 62.84B | | +72.86% | 49.15B | | +18.82% | 38.45B | | +3.27% | 32.61B | | +12.51% | 20.65B | | +13.00% | 16.81B | | +16.25% | 15.14B | | +2.22% | 14.14B |
Other Commodity Chemicals
|